⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186362 | 0.75 | IDO1 (0.50) | — | |
| SCHEMBL8387158 | 0.75 | MTNR1A (0.44) | — | |
| SCHEMBL9132371 | 0.72 | ANPEP (0.40) | — | |
| SCHEMBL466344 | 0.72 | IDO1 (0.53) | — | |
| SCHEMBL16402812 | 0.70 | MEN1 (0.56) | — | |
| SCHEMBL315646 | 0.69 | IDO1 (0.46) | — | |
| SCHEMBL50587 | 0.69 | PRCP (0.47) | — | |
| SCHEMBL30681591 | 0.69 | PRCP (0.47) | — | |
| SCHEMBL7871424 | 0.68 | HTR2A (0.52) | — | |
| SCHEMBL2463276 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5330999-A | Diabetes, obesity | ADIR ET COMPAGNIE (FR) | 1994-07-19 | — | — | US | claimed |
| EP-2772505-B1 | PHOTOCURABLE RESIN COMPOSITION AND NOVEL SILOXANE COMPOUND | ADEKA CORP (JP) | 2017-11-15 | — | — | EP | disclosed |
| US-9063415-B2 | Photocurable resin composition and novel siloxane compound | ADEKA CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2772505-A1 | PHOTOCURABLE RESIN COMPOSITION AND NOVEL SILOXANE COMPOUND | Adeka Corporation (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-20140205949-A1 | PHOTOCURABLE RESIN COMPOSITION AND NOVEL SILOXANE COMPOUND | ADEKA CORPORATION (JP) | 2014-07-24 | — | — | US | disclosed |
| WO-2000058346-A1 | N-SULFONYL-DIPEPTIDE DERIVATIVES, PRODUCTION AND USE THEREOF IN THERAPY | SANOFI-SYNTHELABO (FR) | 2000-10-05 | — | — | WO | disclosed |